In silico assessment of transcriptomic data within the cancer genome atlas (TCGA) database indicated high expression of CD9 and CD81 in all analyzed tumor sets, while expression of TSPAN8 was elevated in particular in hepatocellular carcinoma and colonic adenocarcinoma (Figure 1A). This evidence concerns the gene CD9 and colon adenocarcinoma.